GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401

Yokomizo, A; Shiota, M; Morokuma, F; Eto, M; Matsuyama, H; Matsumoto, H; Kamoto, T; Terada, N; Kawahara, K; Enokida, H; Tatarano, S; Fujimoto, N; Higasijima, K; Sakai, H; Hakariya, T; Igawa, T; Suekane, S; Kamba, T; Sugiyama, Y; Kishimoto, J; Naito, S

Yokomizo, A (通讯作者)，Harasanshin Hosp, Dept Urol, 1-8 Taihakumachi,Hakata Ku, Fukuoka 8120033, Japan.

INTERNATIONAL JOURNAL OF UROLOGY, 2023; ():

Abstract

Objectives: To compare the effectiveness and safety of gonadotropin-releasing hormone (GnRH) antagonist monotherapy to combined androgen blockade (CAB......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索